Mon, April 29, 2024
Tue, March 5, 2024
[ Tue, Mar 05th 2024
] - WOPRAI
Wed, January 3, 2024
[ Wed, Jan 03rd 2024
] - WOPRAI
Tue, August 15, 2023
[ Tue, Aug 15th 2023
] - WOPRAI
Tue, August 8, 2023
[ Tue, Aug 08th 2023
] - WOPRAI
Fri, July 14, 2023
Wed, March 29, 2023
[ Wed, Mar 29th 2023
] - WOPRAI
Mon, October 10, 2022
Fri, September 16, 2022
[ Fri, Sep 16th 2022
] - WOPRAI
Thu, February 11, 2021
[ Thu, Feb 11th 2021
] - WOPRAI
Mon, October 19, 2020
[ Mon, Oct 19th 2020
] - WOPRAI
Tue, March 13, 2018
[ Tue, Mar 13th 2018
] - WOPRAI
Tue, February 6, 2018
[ Tue, Feb 06th 2018
] - WOPRAI
[ Tue, Feb 06th 2018
] - WOPRAI
Mon, October 23, 2017
[ Mon, Oct 23rd 2017
] - WOPRAI
[ Mon, Oct 23rd 2017
] - WOPRAI
Fri, July 28, 2017
[ Fri, Jul 28th 2017
] - WOPRAI
Thu, July 27, 2017
Fri, December 9, 2016
Mon, May 2, 2016
[ Mon, May 02nd 2016
] - WOPRAI
Wed, December 2, 2015
Mon, July 27, 2015
[ Mon, Jul 27th 2015
] - WOPRAI
Thu, March 12, 2015
[ Thu, Mar 12th 2015
] - WOPRAI
Thu, January 22, 2015
[ Thu, Jan 22nd 2015
] - WOPRAI
Thu, October 2, 2014
[ Thu, Oct 02nd 2014
] - WOPRAI
Thu, May 15, 2014
[ Thu, May 15th 2014
] - WOPRAI
Thu, May 16, 2013
Thu, August 2, 2012
Seamus Fernandez Downgraded (ALT) to Hold on, Apr 29th, 2024
Seamus Fernandez of Guggenheim, Downgraded "Altimmune, Inc." (ALT) to Hold on, Apr 29th, 2024.
Seamus has made no other calls on ALT in the last 4 months.
There are 3 other peers that have a rating on ALT. Out of the 3 peers that are also analyzing ALT, 1 agrees with Seamus's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Corinne Jenkins of "Goldman Sachs" Initiated at Hold and Held Target at $13 on, Wednesday, January 24th, 2024
These are the ratings of the 2 analyists that currently disagree with Seamus
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $12 on, Monday, April 1st, 2024
- Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $20 on, Thursday, March 28th, 2024
Contributing Sources